<DOC>
	<DOCNO>NCT02940366</DOCNO>
	<brief_summary>This purpose study evaluate effect high-dose Pitavastatin glucose control patient metabolic syndrome .</brief_summary>
	<brief_title>Effect High-dose Pitavastatin Glucose Control Patients With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Patients diagnose metabolic syndrome accord National cholesterol Education Program criterion Patients hypercholesterolemia require start statin therapy overt diabetes acute coronary syndrome within 2 month acute cerebrovascular event within 2 month recent treatment statin within 1month recent diagnose neoplasm recent diagnose liver disease chronic kidney disease patient myopathy pregnant woman , nurse mother , woman possibility pregnant patient adminstered cyclosporine patient genetic disease galactose intolerance , lactose intolerance , glucosegalactose malabsorption patient treatment cyclosporin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>